Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

This publication has 12 references indexed in Scilit:

• Adenoviral Vectors with E1A Regulated by Tumor-Specific Promoters Are Selectively Cytolytic for Breast Cancer and Melanoma
  Molecular Therapy, 2002
• Replicative adenoviruses for cancer therapy
  Nature Biotechnology, 2000
• Gene therapy: designer promoters for tumour targeting
  Trends in Genetics, 2000
• Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis
  Cancer Gene Therapy, 2000
• Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancer cells but not in normal mesothelial cells
  Cancer Gene Therapy, 1999
• Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig
  Gene Therapy, 1998
• Prostate Tissue Specificity of the Prostate-Specific Antigen Promoter Isolated from a Patient with Prostate Cancer
  Human Gene Therapy, 1995
• Cloning and functional expression of the cDNA encoding rat lanosterol 14-α demethylase
  Gene, 1995
• In VivoAdenovirus-Mediated Gene Transfer of theEscherichia coliCytosine Deaminase Gene to Human Colon Carcinoma-Derived Tumors Induces Chemosensitivity to 5-Fluorocytosine
  Human Gene Therapy, 1995
• Chapter 8 Use of Recombinant Adenovirus for Metabolic Engineering of Mammalian Cells
  Published by Elsevier ,1994